Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Impel Pharmaceuticals Inc. IMPL

Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.


Top institutional share ownership of Impel NeuroPharma, Inc.

Name Shares Shares % change Value Value % change
Kohlberg Kravis Roberts & Co. L.P. 4,135,971 0.0% $38,547 46.3%
5AM Venture Management, LLC 2,884,791 0.0% $26,886 46.3%
Vivo Capital, LLC 2,884,789 0.0% $26,886 46.3%
venBio Partners LLC 2,759,791 0.0% $25,721 46.3%
Vanguard Group Inc 513,868 -3.4% $4,790 41.4%
DCF Advisers, LLC 438,566 19.5% $4,087 74.8%
Lasry Marc 408,329 23.7% $3,806 81.1%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 396,809 0.0% $3,698 46.3%
Opaleye Management Inc. 144,642 $1,348
Millennium Management Llc 144,207 $1,344

Top institutional buyers of Impel NeuroPharma, Inc.

Name Shares % change Value % change Shares Value
FSSNX - Fidelity Small Cap Index Fund 46.2% 6.4% 47,230 $299
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock 40.2% 33.7% 50,165 $346
Lasry Marc 23.7% 81.1% 408,329 $3,806
DCF Advisers, LLC 19.5% 74.8% 438,566 $4,087
IBB - iShares Nasdaq Biotechnology ETF 13.3% 65.8% 56,798 $529
IWO - iShares Russell 2000 Growth ETF 0.5% -26.1% 30,406 $194

Top institutional sellers of Impel NeuroPharma, Inc.

Name Shares % change Value % change Shares Value
State Street Corp -76.8% -66.1% 41,700 $389
BlackRock Inc. -71.8% -58.8% 97,471 $908
Geode Capital Management, Llc -28.8% 4.2% 115,185 $1,073
Bank of New York Mellon Corp -27.2% 6.9% 35,030 $327
Vanguard Group Inc -3.4% 41.4% 513,868 $4,790
IWM - iShares Russell 2000 ETF -2.5% -28.0% 123,750 $788

Information provided by Fintel.io